Pharmagest Interactive SA
F:PHF

Watchlist Manager
Pharmagest Interactive SA Logo
Pharmagest Interactive SA
F:PHF
Watchlist
Price: 33.85 EUR -1.02% Market Closed
Market Cap: €508.9m

Wall St Price Targets

PHF Price Targets Summary
Pharmagest Interactive SA

Wall Street analysts forecast PHF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHF is 61.48 EUR with a low forecast of 58.58 EUR and a high forecast of 65.68 EUR.

Lowest Forecast
Price Target
58.58 EUR
73% Upside
Average Forecast
Price Target
61.48 EUR
82% Upside
Highest Forecast
Price Target
65.68 EUR
94% Upside
Pharmagest Interactive SA Competitors:
Price Targets
WHF
WhiteHorse Finance Inc
22% Upside
TMP
Tompkins Financial Corp
-9% Downside
DRT
DIRTT Environmental Solutions Ltd
80% Upside
GILT
Gilat Satellite Networks Ltd
78% Upside

Revenue
Forecast

7% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
7% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 8%.

Gross Profit
Forecast

8% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
8% / Year
Past Growth
-4% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 6 years is -4%.

Operating Income
Forecast

7% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
7% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 12%.

Pre-Tax Income
Forecast

8% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 15%.

Net Income
Forecast

9% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
9% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PHF's stock price target?
Price Target
61.48 EUR

According to Wall Street analysts, the average 1-year price target for PHF is 61.48 EUR with a low forecast of 58.58 EUR and a high forecast of 65.68 EUR.

What is the Revenue forecast for Pharmagest Interactive SA?
Projected CAGR
8%

Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for Pharmagest Interactive SA?
Projected CAGR
-4%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 6 years is -4%.

What is the Operating Income forecast for Pharmagest Interactive SA?
Projected CAGR
12%

Over the last 14 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 3 years is 12%.

What is the Pre-Tax Income forecast for Pharmagest Interactive SA?
Projected CAGR
15%

Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Pharmagest Interactive SA?
Projected CAGR
14%

Over the last 14 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett